Nan Zhang

Publication Activity (10 Years)

Years Active: 2021-2024
Publications (10 Years): 5

Top Topics

Machine Learning

Top Venues

Antimicrobial agents and chemotherapy

The European respiratory journal

CPT: pharmacometrics & systems pharmacology

This page only lists publications with an associated author ORCID identifier.

Publications

Janice J N Goh, Qianwen Wang, Nan Zhang, Niurys de Castro Suarez, Annamarie E Bustion, Eric L Nuermberger, Radojka M Savic
Prospectively predicting BPaMZ phase IIb/III trial outcomes using a translational mouse-to-human platform. Antimicrobial agents and chemotherapy (2024)
Nan Zhang, Ming Liang Chan, Jing Li, Philip Z Brohawn, Bo Sun, Inna Vainshtein, Lorin K Roskos, Raffaella Faggioni, Rada M Savic
Combining Pharmacometric Models with Predictive and Prognostic Biomarkers for Precision Therapy in Crohn's Disease: A Case Study of Brazikumab. CPT: pharmacometrics & systems pharmacology (2023)
Jacqueline P Ernest, Janice Jia Ni Goh, Natasha Strydom, Qianwen Wang, Rob Christiaan van Wijk, Nan Zhang, Amelia Deitchman, Eric L Nuermberger, Radojka M Savic
Translational predictions of phase 2a first-in-patient efficacy studies for antituberculosis drugs. The European respiratory journal (2023)
Nan Zhang, Radojka M Savic, Martin J Boeree, Charles A Peloquin, Marc Weiner, Norbert Heinrich, Erin Bliven-Sizemore, Patrick Peter John Phillips, Michael Hoelscher, William Whitworth, Glenn Morlock, James Posey, Jason E Stout, William Mac Kenzie, Robert Aarnoutse, Kelly E Dooley, null null
Optimising pyrazinamide for the treatment of tuberculosis. The European respiratory journal 58 (1) (2021)
Kendra K Radtke, Jacqueline P Ernest, Nan Zhang, Nicole C Ammerman, Eric L Nuermberger, Robert Belknap, Rosanna Boyd, Timothy R Sterling, Radojka M Savic
Comparative Efficacy of Rifapentine Alone and in Combination with Isoniazid for Latent Tuberculosis Infection: a Translational Pharmacokinetic-Pharmacodynamic Modeling Study. Antimicrobial agents and chemotherapy 65 (12) (2021)